Breaking News

ProPharma Group Acquires PI

By Kristin Brooks | January 15, 2014

Establishes global medical information services firm

ProPharma Group, a compliance services company, has acquired Professional Information Ltd. (PI), a provider of medical information services.  The acquisition creates a global medical information (MI) service organization by combining PI with Advanced Response Management (ARM), a subsidiary of ProPharma Group that provides MI services in the U.S., resulting in a large, global organization exclusively focused on MI.
 
PI, headquartered in Richmond, UK with an office in Melbourne, Australia, handles medical information inquiries, capturing and reporting adverse events, and medical information-writing services throughout Europe, the Middle East, Africa, and Asia-Pacific, supporting more than 22 languages. ARM provides Medical Information services in the U.S., Canada, and Latin America through its Overland Park, KS offices.
 
Jeff Hargroves, president of ProPharma Group, said,  “ARM and PI have been successfully providing integrated global MI services for two years in a formal partnership. Our current and future clients will benefit from the seamless integration of data compilation and reporting across the globe. The two companies share a common vision of care for colleagues and clients, and we therefore anticipate a very smooth transition into a single corporate entity.”
 
Following the acquisition, Rachel Lilley, managing director at PI, and Keith Lilley, director of business development, will continue in their current roles.  “We are very excited to work closely with our U.S. counterparts to expand our current high quality, customer-oriented service globally,” said Ms. Lilley.

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016